- Home
- PAYC vs RGEN Comparison
PAYC vs RGEN Comparison
Compare PAYC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYC
- RGEN
- Stock Information
- Founded
- PAYC 1998
- RGEN 1981
- Country
- PAYC United States
- RGEN United States
- Employees
- PAYC N/A
- RGEN N/A
- Industry
- PAYC Computer Software: Prepackaged Software
- RGEN Medical/Dental Instruments
- Sector
- PAYC Technology
- RGEN Health Care
- Exchange
- PAYC Nasdaq
- RGEN Nasdaq
- Market Cap
- PAYC 9.4B
- RGEN 8.2B
- IPO Year
- PAYC 2014
- RGEN N/A
- Fundamental
- Price
- PAYC $169.07
- RGEN $140.00
- Analyst Decision
- PAYC Hold
- RGEN Buy
- Analyst Count
- PAYC 18
- RGEN 10
- Target Price
- PAYC $179.62
- RGEN $188.38
- AVG Volume (30 Days)
- PAYC 742.2K
- RGEN 783.2K
- Earning Date
- PAYC 10-29-2024
- RGEN 10-29-2024
- Dividend Yield
- PAYC 0.88%
- RGEN N/A
- EPS Growth
- PAYC 51.60
- RGEN N/A
- EPS
- PAYC 8.25
- RGEN N/A
- Revenue
- PAYC $1,778,291,000.00
- RGEN $602,354,000.00
- Revenue This Year
- PAYC $12.48
- RGEN $0.08
- Revenue Next Year
- PAYC $11.08
- RGEN $12.97
- P/E Ratio
- PAYC $20.50
- RGEN N/A
- Revenue Growth
- PAYC 14.17
- RGEN N/A
- 52 Week Low
- PAYC $139.50
- RGEN $110.45
- 52 Week High
- PAYC $279.96
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- PAYC 61.87
- RGEN 41.03
- Support Level
- PAYC $160.97
- RGEN $138.80
- Resistance Level
- PAYC $165.15
- RGEN $150.72
- Average True Range (ATR)
- PAYC 4.46
- RGEN 5.04
- MACD
- PAYC 0.77
- RGEN -1.06
- Stochastic Oscillator
- PAYC 83.28
- RGEN 8.50
About PAYC Paycom Software Inc.
Paycom is a fast-growing provider of payroll and human capital management software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 19,500 clients as of 2023, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.